Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W. Eikelboom, Sanjit S. Jolly, Emilie P. Belley‐Côté, Richard Whitlock, Sumathy Rangarajan, Lizhen Xu, Laura Heenan, Shrikant I. Bangdiwala, Wadea Tarhuni, Mohamed Hassany, А. V. Kontsevaya, William Harper, Sanjib Kumar Sharma, Patricio López‐Jaramillo, Antonio L Dans, Lia M. Palileo‐Villanueva, Álvaro Avezum, Prem Pais, Denis Xavier, Camilo Félix, Afzalhussein Yusufali, Renato D. Lópes, Otávio Berwanger, Zeeshan Ali, Sean Wasserman, Sonia S. Anand, Jackie Bosch, Shurjeel Choudhri, Michael E. Farkouh, Mark Loeb, Salim Yusuf
Topics & Concepts
MedicineAspirinRandomized controlled trialPopulationInternal medicineClinical trialIntention-to-treat analysisPhysical therapyEnvironmental healthCOVID-19 Clinical Research StudiesInflammasome and immune disordersDermatological and COVID-19 studies